1st Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases, Issues related to COVID-19

LobbyistCovered position, as disclosed
NADEAM ELSHAMI —
MARC LAMPKIN —
BRIAN MCKEON —
RADHA MOHAN —
ZACHARY PFISTER —
BRIAN WILD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Veterans VET

Opportunities for health care collaboration

LobbyistCovered position, as disclosed
ARACELI GUTIERREZ —
ZACHARY PFISTER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Medical/Disease Research/Clinical Labs MED

Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases, Issues related to COVID-19 treatment H.R.1319 - American Rescue Plan Act of 2021

LobbyistCovered position, as disclosed
EMILY FELDER —

Contacted: SENATE; Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1319 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.